<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Ji GW</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Accurate prognosis assessment is essential for surgically resected intrahepatic cholangiocarcinoma (ICC) while published prognostic tools are limited by modest performance. We therefore aimed to establish a novel model to predict survival in resected ICC based on readily-available clinical parameters using machine learning technique.&lt;h4>Methods&lt;/h4>A gradient boosting machine (GBM) was trained and validated to predict the likelihood of cancer-specific survival (CSS) on data from a Chinese hospital-based database using nested cross-validation, and then tested on the Surveillance, Epidemiology, and End Results (SEER) database. The performance of GBM model was compared with that of proposed prognostic score and staging system.&lt;h4>Results&lt;/h4>A total of 1050 ICC patients (40</pubmed_abstract><journal>BMC cancer</journal><pagination>258</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8915487</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma.</pubmed_title><pmcid>PMC8915487</pmcid><pubmed_authors>Li XC</pubmed_authors><pubmed_authors>Ji GW</pubmed_authors><pubmed_authors>Jiao CY</pubmed_authors><pubmed_authors>Wang XH</pubmed_authors><pubmed_authors>Xu ZG</pubmed_authors><pubmed_authors>Wang K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma.</name><description>&lt;h4>Background&lt;/h4>Accurate prognosis assessment is essential for surgically resected intrahepatic cholangiocarcinoma (ICC) while published prognostic tools are limited by modest performance. We therefore aimed to establish a novel model to predict survival in resected ICC based on readily-available clinical parameters using machine learning technique.&lt;h4>Methods&lt;/h4>A gradient boosting machine (GBM) was trained and validated to predict the likelihood of cancer-specific survival (CSS) on data from a Chinese hospital-based database using nested cross-validation, and then tested on the Surveillance, Epidemiology, and End Results (SEER) database. The performance of GBM model was compared with that of proposed prognostic score and staging system.&lt;h4>Results&lt;/h4>A total of 1050 ICC patients (40</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-22T12:57:25.475Z</modification><creation>2025-04-06T00:24:22.898Z</creation></dates><accession>S-EPMC8915487</accession><cross_references><pubmed>35277130</pubmed><doi>10.1186/s12885-022-09352-3</doi></cross_references></HashMap>